Clinical Trial: Efficacy and Safety of LAS41003 in the Treatment of Superficial Infected Eczema

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Explorative, Double-blind, Randomized, Controlled Multi-center Phase II Study to Evaluate the Efficacy and Safety of Topically Applied LAS41003 Once Daily Versus LAS189962 and LAS189961 in the Treatme

Brief Summary: The aim of the study is to determine the efficacy and safety of topical application of LAS41003 in comparison to LAS189962 and LAS189961 in the treatment of superinfected eczema.

Detailed Summary:
Sponsor: Almirall, S.A.

Current Primary Outcome: Combination of clinical and microbial treatment success [ Time Frame: Day 14 ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Safety:Physical examination at EoT, AEs/SAEs during the entire study [ Time Frame: 2 weeks ]

Original Secondary Outcome: Same as current

Information By: Almirall, S.A.

Dates:
Date Received: November 24, 2009
Date Started: November 2009
Date Completion:
Last Updated: July 8, 2010
Last Verified: July 2010